Inter-rater concordance study of the PASI (Psoriasis Area and Severity Index);Importância da variação do PASI realizado por diversos observadores

Anais Brasileiros de Dermatologia

Volumn 85, Issue 5, 2010, Pages 625-628

  De Faria, Joana Ribeiro Costa ^a,b   Aarão, Aline Rezende ^a,b   Jimenez, Luiz Miguel Zabaleta ^a,b   Silva, Oscar Hernández ^a,b   Avelleira, João Carlos Regazzi ^b,c  

^a Dermatology Service   (Brazil)

^b Professor Rubem David Azulay Institute of Dermatology   (Brazil)

^c Santa Casa de Misericórdia do Rio de Janeiro   (Brazil)

Author keywords

Cross sectional studies; Psoriasis; Reproducibility of results

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION COEFFICIENT; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; INTERRATER RELIABILITY; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS SEVERITY INDEX; REPRODUCIBILITY;

EID: 78650439328     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/s0365-05962010000500005     Document Type: Article

References (7)

1. Azulay RD, Azulay DR. Dermatologia. 4 ed. Rio de Janeiro: Guanabara Koogan; 2006.
2. Carlin CS, Feldman SR, Krueger JG, Menter A, Krueger GG. A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. J Am Acad Dermatol. 2004;50:859-66.
3. Jacobson CC, Kimball AB. Rethinking the psoriasis area and severity index: the impact of area should be increased. Br J Dermatol. 2004;151:381-7.
4. Berth-Jones J, Grotzinger K, Rainville C, Pham B, Huang J, Daly S, et al. A study examining inter-and intrarrater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment. Br J Dermatol. 2006;155:707-13.
5. Bartko JJ, Carpenter WT Jr. On the methods and theory of reliability. J Nerv Ment Dis. 1976;163:307-17.
6. Langley RG, Ellis CN. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J Am Acad Dermatol. 2004;51:563-9.
7. Grob JJ. Why are quality of life instruments not recognized as reference measures in therapeutic trials of chronic skin disorders? J Invest Dermatol. 2007;127:2299-301.